Apellis Pharmaceuticals, Inc.

NasdaqGS:APLS Stock Report

Market Cap: US$3.4b

Apellis Pharmaceuticals Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NasdaqGS:APLS Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
16 Sep 24SellUS$6,952James ChopasIndividual192US$36.21
03 Sep 24SellUS$21,720James ChopasIndividual550US$39.49
19 Mar 24SellUS$1,068,161Epidarex CapitalCompany18,681US$57.18
18 Mar 24SellUS$564,050Mark DelongIndividual9,913US$56.90
15 Mar 24SellUS$10,389James ChopasIndividual184US$56.46
13 Mar 24SellUS$645,838Nur NicholsonIndividual11,220US$58.13
12 Feb 24SellUS$40,457Mark DelongIndividual597US$67.77
12 Feb 24SellUS$96,974Timothy SullivanIndividual1,431US$67.77
12 Feb 24SellUS$77,796Adam TownsendIndividual1,148US$67.77
12 Feb 24SellUS$52,926David WatsonIndividual781US$67.77
12 Feb 24SellUS$268,492Cedric FrancoisIndividual3,962US$67.77
12 Feb 24SellUS$77,796Pascal DeschateletsIndividual1,148US$67.77
29 Jan 24SellUS$23,539Mark DelongIndividual367US$64.14
29 Jan 24SellUS$17,895Jeffrey EiseleIndividual279US$64.14
29 Jan 24SellUS$182,345Cedric FrancoisIndividual2,843US$64.14
29 Jan 24SellUS$56,057Pascal DeschateletsIndividual874US$64.14
29 Jan 24SellUS$58,109Adam TownsendIndividual906US$64.14
29 Jan 24SellUS$58,109David WatsonIndividual906US$64.14
29 Jan 24SellUS$53,555Nur NicholsonIndividual835US$64.14
29 Jan 24SellUS$58,109Timothy SullivanIndividual906US$64.14
29 Jan 24SellUS$23,539Karen LewisIndividual367US$64.14
22 Jan 24SellUS$254,329Pascal DeschateletsIndividual3,913US$65.00
22 Jan 24SellUS$221,831Adam TownsendIndividual3,413US$65.00
22 Jan 24SellUS$271,943David WatsonIndividual4,184US$65.00
22 Jan 24SellUS$112,963Karen LewisIndividual1,738US$65.00
22 Jan 24SellUS$168,535Nur NicholsonIndividual2,593US$65.00
22 Jan 24SellUS$230,801Timothy SullivanIndividual3,551US$65.00
22 Jan 24SellUS$89,954Mark DelongIndividual1,384US$65.00
22 Jan 24SellUS$68,961James ChopasIndividual1,061US$65.00
22 Jan 24SellUS$104,449Jeffrey EiseleIndividual1,607US$65.00
22 Jan 24SellUS$872,961Cedric FrancoisIndividual13,431US$65.00
16 Jan 24SellUS$524,514Cedric FrancoisIndividual7,851US$66.81
16 Jan 24SellUS$109,032Karen LewisIndividual1,632US$66.81
16 Jan 24SellUS$149,317Timothy SullivanIndividual2,235US$66.81
16 Jan 24SellUS$124,064Nur NicholsonIndividual1,857US$66.81
16 Jan 24SellUS$109,032Pascal DeschateletsIndividual1,632US$66.81
16 Jan 24SellUS$149,317Adam TownsendIndividual2,235US$66.81
16 Jan 24SellUS$283,268David WatsonIndividual4,240US$66.81
16 Jan 24SellUS$29,262Jeffrey EiseleIndividual438US$66.81
16 Jan 24SellUS$108,965Mark DelongIndividual1,631US$66.81
16 Jan 24SellUS$57,723James ChopasIndividual864US$66.81
04 Jan 24SellUS$165,207Caroline BaumalIndividual2,751US$60.05
26 Dec 23SellUS$3,935Jeffrey EiseleIndividual68US$57.86
01 Dec 23SellUS$1,467,240Epidarex CapitalCompany24,000US$61.14

Insider Trading Volume

Insider Buying: APLS insiders have only sold shares in the past 3 months.

Ownership Breakdown

What is the ownership structure of APLS?
Owner TypeNumber of SharesOwnership Percentage
State or Government45,6250.0331%
Individual Insiders4,183,4883.04%
VC/PE Firms12,806,3429.3%
Hedge Funds23,001,95416.7%
Institutions97,653,46170.9%

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 5%.

Top Shareholders

Top 25 shareholders own 91.03% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
12.5%
Wellington Management Group LLP
15,566,969US$427.9m-5.01%0.06%
10.3%
The Morningside Group Limited
12,806,342US$352.0m0%74.76%
9.56%
EcoR1 Capital, LLC
11,890,843US$326.9m2.44%10.93%
8.93%
Avoro Capital Advisors LLC
11,111,111US$305.4m0%4.14%
7.89%
The Vanguard Group, Inc.
9,815,575US$269.8m0.06%no data
4.98%
BlackRock, Inc.
6,191,937US$170.2m6.84%no data
3.54%
Deep Track Capital, LP
4,400,654US$121.0m76%3.59%
3.25%
State Street Global Advisors, Inc.
4,040,861US$111.1m-2.55%no data
3.06%
JP Morgan Asset Management
3,808,257US$104.7m21.6%0.01%
2.7%
T. Rowe Price Group, Inc.
3,363,728US$92.5m-36.8%0.01%
2.64%
Morgan Stanley, Investment Banking and Brokerage Investments
3,281,668US$90.2m62.8%0.01%
2.51%
Braidwell LP
3,125,183US$85.9m411%3.69%
2.42%
Octagon Capital Advisors LP
3,006,980US$82.7m4.38%13.11%
2.33%
FMR LLC
2,896,894US$79.6m-12.2%no data
1.74%
The Invus Group, LLC
2,167,224US$59.6m0%2.71%
1.72%
Assenagon Asset Management S.A.
2,144,415US$58.9m192%0.1%
1.46%
Jennison Associates LLC
1,821,115US$50.1m-49.3%0.03%
1.46%
Geode Capital Management, LLC
1,810,526US$49.8m1.26%no data
1.39%
Tavistock Life Sciences
1,726,000US$47.4m0%2.98%
1.38%
Deutsche Asset & Wealth Management
1,722,372US$47.3m-5.34%0.01%
1.38%
Cedric Francois
1,711,187US$47.0m-6.71%no data
1.09%
Fiera Capital Corporation
1,354,469US$37.2m-3.33%0.08%
1.02%
OrbiMed Advisors LLC
1,270,400US$34.9m-2.49%0.46%
0.9%
Pascal Deschatelets
1,113,897US$30.6m0%no data
0.87%
Polar Capital Holdings Plc
1,082,000US$29.7m0.24%0.11%